glp 1 plateau Your Has A Name #metabolichealth #insulinresistance Glp-1 plateau: reasons and solutions

The team looked at data from 5,260 people who were representative of the general population and who responded to a survey conducted in early 2025

The geography of coverage amplifies an ongoing problem with racial difference in access, with studies showing Black people to be less likely to receive prescriptions for GLP-1s, despite being more likely to be affected by obesity

GLP-1 medications slow down gastric emptying

The results showed that over 72 weeks, patients on the 10 mg dose lost an average of about 12.8% of their body weight, and those on the 15 mg dose lost an average of 14.7% of their body weight

Canadian officials said they are also reviewing applications for six other generic medications with the ingredient semaglutide

It helps promote relaxation and maintain a positive mood